However, we only detected the effects of specific inhibitors on the expression levels of PI3K/Akt/Nrf2 pathway-related proteins but did not determine whether these inhibitors could reverse the neuroprotective effects of EA in vivo and in vitro. The gene discussed is AKT1; the disease is Esophageal atresia.